Photodynamic Effects with 5-Aminolevulinic Acid on Cytokines and Exosomes in Human Peripheral Blood Mononuclear Cells from Patients with Crohn’s Disease
Autor: | Kristian Espeland, Andrius Kleinauskas, Petras Juzenas, Sagar Darvekar, Vlada Vasovic, Trond Warloe, Eidi Christensen, Jørgen Jahnsen, Qian Peng |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2023 |
Předmět: |
Crohn’s disease
flow cytometry Organic Chemistry peripheral blood mononuclear cells (PBMCs) autoimmune disease General Medicine Catalysis Computer Science Applications photodynamic therapy (PDT) Inorganic Chemistry 5-aminolevulinic acid (ALA) extracorporeal photopheresis (ECP) cytokine exosome Physical and Theoretical Chemistry protoporphyrin IX (PpIX) Molecular Biology Spectroscopy |
Zdroj: | International Journal of Molecular Sciences Volume 24 Issue 5 Pages: 4554 |
ISSN: | 1422-0067 |
DOI: | 10.3390/ijms24054554 |
Popis: | Photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) which is the precursor of the photosensitizer protoporphyrin IX (PpIX) is an available treatment for several diseases. ALA-PDT induces the apoptosis and necrosis of target lesions. We have recently reported the effects of ALA-PDT on cytokines and exosomes of human healthy peripheral blood mononuclear cells (PBMCs). This study has investigated the ALA-PDT-mediated effects on PBMC subsets from patients with active Crohn’s disease (CD). No effects on lymphocyte survival after ALA-PDT were observed, although the survival of CD3−/CD19+ B-cells seemed slightly reduced in some samples. Interestingly, ALA-PDT clearly killed monocytes. The subcellular levels of cytokines and exosomes associated with inflammation were widely downregulated, which is consistent with our previous findings in PBMCs from healthy human subjects. These results suggest that ALA-PDT may be a potential treatment candidate for CD and other immune-mediated diseases. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |